drugset / Trial / NCT01718288
Optimization of Treatment in Patients With Severe Peripheral Ischemia (Fontaine Stage IIb)
RandomizedParallel-groupOpen-labelTreatment
Summary
Evaluate the possibility of optimization of therapy with prostanoids (iloprost), in patients with Fontaine's stage IIb severe chronic ischemia, both in patients eligible for surgery both in patients for which it is only possible medical therapy
Timeline
- Start
- 2006-11
- Primary completion
- 2011-03
- Completion
- 2012-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Iloprost | Other / unclassified | — | Intravenous |
| Background | Aspirin | Small molecule | — | — |
| Background | Defibrotide | Oligonucleotide (other) | — | — |
| Background | Heparin | Other / unclassified | — | — |
| Background | LEVOCARNITINE PROPIONATE | Small molecule | — | — |
| Background | Pentoxifylline | Small molecule | — | — |
| Background | buflomedil | Small molecule | — | — |